Insider holders · CIK 0001029125
Sun BioPharma, Inc. · SNBP
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Donald Robert SchemelDirector | 894,288 | 2,826,548 | 3,720,836 | Dec 1, 2016 · 5:07 pm EST | Form 4 |
| Paul W. SchafferDirector | 899,204 | 200,848 | 1,100,052 | Jun 14, 2018 · 5:06 pm EDT | Form 4 |
| Ryan Randall Gilbertson10% Owner | 555,538 | 0 | 555,538 | Jan 24, 2019 · 11:59 am EST | Form 4 |
| Suzanne GagnonDirector | 430,000 | — | 430,000 | Jun 28, 2016 · 12:31 pm EDT | Form 4 |
| Thomas X. NeenanChief Scientific Officer | 400,000 | — | 400,000 | Sep 14, 2015 · 5:33 pm EDT | Form 3 |
| Michael T. CullenExecutive Chairman | 157,500 | 194,576 | 352,076 | Feb 22, 2018 · 5:37 pm EST | Form 4 |
| David Michael Fuhrmanrelationship not stated | 158,175 | — | 158,175 | Nov 10, 2015 · 7:16 pm EST | Form 4 |
| Robert John SargentDirector | 0 | 74,825 | 74,825 | Nov 10, 2015 · 7:21 pm EST | Form 4 |
| David B KaysenPresident and CEO | 51,000 | — | 51,000 | Jun 14, 2018 · 5:20 pm EDT | Form 4 |
| Scott KellenChief Financial Officer | 4,500 | — | 4,500 | Feb 22, 2018 · 5:28 pm EST | Form 4 |
| Jeffrey S MathiesenDirector | 3,000 | — | 3,000 | Feb 22, 2018 · 5:30 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.